Kingdon Capital Management
https://www.kingdon.com/Kingdon Capital Management, an employee hedge fund, invests in the public equity, fixed income, and alternative investment markets around the world. The fund was founded in 1983 by Mark E. Kingdon.
View Older Stories
-
Form SCHEDULE 13G OptiNose, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A CURIS INC Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G CURIS INC Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
-
Form SC 13G/A Praxis Precision Medicin Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A Applied Minerals, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A SCYNEXIS INC Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
enVVeno Medical (NVNO) Announces $28M Private Placement at $5.81/sh
-
enVVeno Medical Announces Private Placement of $28 Million
-
NioCorp Announces Closing of US$2.0 Million Registered Direct Offering
-
NioCorp Developments (NB) Announces 315K Share Offering at $6.36/sh
-
NioCorp Announces US $2.0 Million Registered Direct Offering
-
Form SC 13G SCYNEXIS INC Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Lincoln Financial (LNC) names Christopher Neczypor CFO
-
Lincoln Financial Group Appoints Christopher Neczypor Chief Financial Officer
-
Form SC 13G/A Applied Minerals, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G Praxis Precision Medicin Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Wedbush Securities’ Senior Vice President, Equity Research, Gerald, Pascarelli, CFA® Initiates Coverage on U.S. Cannabis Names CRLBF, CURLF, GTBIF & TCNNF
-
Wedbush Securities Equity Research Welcomes Veteran Consumer Analyst Gerald Pascarelli, CFA® as Senior Vice President, Equity Research, Beverages; Initiates Coverage on CELH, KDP, MNST, PEP, KO, SAM,
-
Form SC 13G/A Applied Minerals, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Bottomline Technologies (EPAY) Appoints Philip Hilal, Larry Klane and Michael Curran to its Board
-
Bottomline Appoints Three New Directors to Board of Directors
-
Northleaf Continues US Expansion with Addition of Sarah Silverman as a Managing Director in New York
-
Jasper Therapeutics, Amplitude Healthcare Acquisition (AMHCU) Announce Merger to Create Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
-
Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
-
Form SC 13G Applied Minerals, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong
-
Imago BioSciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference
-
Imago BioSciences Raises $80 Million in Series C Financing
-
Form SC 13G/A Sesen Bio, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A GTY Technology Holdings Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A Jaguar Health, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Athenex (ATNX) Announces $60 Million Private Placement of Common Stock
-
Athenex Announces $60 Million Private Placement
-
Athenex Announces $60 Million Private Placement
-
Form 4 Destination Maternity For: Jul 22 Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A Jaguar Health, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A Sesen Bio, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G GTY Technology Holdings Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form 4 Destination Maternity For: Jan 22 Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form 4 Destination Maternity For: Jan 15 Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
FocusPoint Private Capital Group adds Russell Boggess to its North American Distribution Team
-
Sol-Gel Technologies (SLGL) Appoints Jonathan B. Siegel to Board
-
Sol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors
-
Sol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors
-
Form SC 13D Applied Minerals, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Investor Group Issues Open Letter to Shareholders of Destination Maternity Corporation
-
Form SC 13G Eleven Biotherapeutics, Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G/A AIT Therapeutics, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.
-
Form SC 13G AIT Therapeutics, Inc. Filed by: KINGDON CAPITAL MANAGEMENT, L.L.C.

